openPR Logo
Press release

Biologics and Biosimilars Market - Growing Trends and Business Opportunities by Pfizer Inc.,AstraZeneca,Novartis Global,Merck & Co. Inc.,Smiths Medical,GlaxoSmithKline Plc.,Concord Biotech and other

10-30-2018 10:21 AM CET | Health & Medicine

Press release from: Allied Market Research

Biologics and Biosimilars Market

Biologics and Biosimilars Market

The major factors of the Biologics and Biosimilars Market that contribute to the growth include increase in the prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and rise in geriatric population. Moreover, large numbers of clinical trials and innovative R&D approaches to develop advanced drugs drive the market growth. However, manufacturing difficulties due to complexity of drug molecules hinder the market growth. Increase in R&D activities in the field of pharmaceutical industries and rise in therapeutical applications are anticipated to provide new opportunities for the market.

Biologics therapeutics drugs are genetically engineered proteins derived from human genetic material. Biologics therapeutics contains sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Moreover, these drugs are approved by FDA due to their similar therapeutical actions as biologics.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4046?utm_source=sy-Openpr

List of players profiled in the report
• Pfizer Inc.
• AstraZeneca
• Novartis Global
• Merck & Co. Inc.
• Smiths Medical
• GlaxoSmithKline Plc.
• Concord Biotech
• Aurobindo Pharma Ltd.
• H. Lundbeck A/S
• Retractable Technologies, Inc.

The biologics and biosimilars market is segmented on the basis of type, application, and region. Based on type, the market is divided into antibody, hormone, and growth-factor. By application, it is categorized into tumor, diabetes, cardiovascular, hemophilia, and others. By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4046?utm_source=sy-Openpr

Key Benefits
• The study provides an in-depth analysis of the biologic and biosimilars market with current trends and future estimations to elucidate investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
• The report offers a quantitative analysis to assist stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of different segments helps determine various products available in the market.
• Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.

Access Full Summery @ https://www.alliedmarketresearch.com/biologics-and-biosimilars-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biologics and Biosimilars Market - Growing Trends and Business Opportunities by Pfizer Inc.,AstraZeneca,Novartis Global,Merck & Co. Inc.,Smiths Medical,GlaxoSmithKline Plc.,Concord Biotech and other here

News-ID: 1338363 • Views:

More Releases from Allied Market Research

Cristobalite Market Insights, Size, Share, Overview And Growth Report 2031
Cristobalite Market Insights, Size, Share, Overview And Growth Report 2031
According to the report from Allied Market Research, the global cristobalite market reached $36.3 million in 2021, with an estimated growth to $56.6 million by 2031, displaying a CAGR of 4.6% from 2022 to 2031. This report offers an in-depth analysis of market dynamics, major segments, value chain, competitive landscape, and regional trends, providing valuable insights for stakeholders to develop sustainable strategies and gain a competitive edge. Cristobalite, a mineral polymorph
Glycol Ethers Global Market Report 2021 - By Growth, Trends, Size, Share, Forecast To 2030
Glycol Ethers Global Market Report 2021 - By Growth, Trends, Size, Share, Foreca …
Allied Market Research has released a report titled "Glycol Ethers Market by Type (E-series and P-series), Application (Solvent, Anti-icing, Hydraulic and Brake Fluid, and Chemical Intermediates), End Use (Paints & Coatings, Printing, Pharmaceuticals, Cosmetics & Personal Care, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the global glycol ethers industry was valued at $6.5 billion in 2020 and is projected to reach $11.5 billion by
Pain Management Drugs Market Size, Share, Trends, Growth, and Revenue Projections by 2030
Pain Management Drugs Market Size, Share, Trends, Growth, and Revenue Projection …
According to the report, the global Pain Management Drugs Market size was estimated at USD 71.43 billion in 2019, and is anticipated to hit USD 91.64 billion by 2027, registering a CAGR of 3.8% from 2020 to 2027. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-for-customization/404?reqfor=covid 𝐃𝐫𝐢𝐯𝐞𝐫𝐬, 𝐫𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬, 𝐚𝐧𝐝 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬- Increase in prevalence of chronic diseases, favorable regulatory scenario, and surge in the number of geriatric population drive the growth of the global
Ceramic Injection Molding Market is projected to reach $746.2 million in 2026, growing at a CAGR of 8.8%
Ceramic Injection Molding Market is projected to reach $746.2 million in 2026, g …
global ceramic injection molding market was valued at $375.0 million in 2018 and is expected to reach $746.2 million by 2026, growing at a CAGR of 8.8%. Ceramic injection molding (CIM) is a subset of the powder injection molding (PIM) process used for mass-producing intricate ceramic parts. This technology enables the production of precision components with complex geometries, including bearings, sockets, dental implants, mobile phone buttons, and laptop keypads, with

All 5 Releases


More Releases for Biologics

Biopharmaceutical CMO Market 2020 Business Scenario – Lonza, Boehringer Ingelh …
The report provides a valuable source of insightful data for business strategists and competitive analysis of Biopharmaceutical CMO Market. It provides the Biopharmaceutical CMO industry overview with growth analysis and futuristic cost, revenue and many other aspects. The research analysts provide an elaborate description of the value chain and its distributor analysis. This Tire Biopharmaceutical CMO study provides comprehensive data which enhances the understanding, scope and application of this report. the
Extracellular Matrix Market Detailed Analysis 2020: Top Companies like Coloplast …
The global extracellular matrix market by raw material segments was led by porcine segment. In 2018, the porcine segment held a largest market share of 41.09% of the extracellular matrix market, by raw material. However, the bovine segment is expected to be the fastest growing segments of the market in 2027 owing to more beneficial properties to treat various conditions which is expected to become the major factor for the
Biopharmaceutical CMO Market 2018-2023 :Lonza, Boehringer Ingelheium, Samsung Bi …
Global Biopharmaceutical CMO Industry - A Global Market Overview (2018-2023) (Avail A 10% Off) The "Global Biopharmaceutical CMO Market Research Report 2018-2023" is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides
Global Biopharmaceutical CMO Market Key Profiles - Wuxi Biologics, Boehringer In …
Global Biopharmaceutical CMO Market was valued at USD 13296.29 million in the year 2019. Escalating number of patients suffering from various diseases with growing investment in the healthcare industry by government in major economies and increasing awareness among consumers regarding impact of various viruses on health, has been anticipated to infuse growth in the market for Biopharmaceutical CMO during the forecasting period of 2020-2025. Get Free Sample Copy of this Research
Plant-based Biologics
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Global Biopharmaceutical CMO Market 2018-2023| Lonza, Boehringer Ingelheium, Sam …
Albany, NY, 10th September : Recent research and the current scenario as well as future market potential of "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) - By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" globally. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to